|
|
![]() |
Previous Study | Return to Search Results | Next Study | ![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Shalvata Mental Health Center Brainsway |
| Information provided by: | Shalvata Mental Health Center |
| ClinicalTrials.gov Identifier: | NCT00445237 |
Purpose
This study is evaluating the safety and feasibility of the novel deep TMS H-coil designs in the treatment of resistant major depression in an open study using two different H-coil designs.
| Condition | Intervention | Phase |
|
Major Depression |
Device: H1 and H2 deep TMS coils |
Phase I |
| MedlinePlus related topics: | Depression |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | Evaluation of the H1 Coil and H2 Coil TMS Device - Safety and Feasibility in Major Depression Episode |
Eligibility
| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Eiran V Harel | 972-9-7478644 | evharel@clalit.org.il |
| Israel | |||||
| Shalvata MHC | Recruiting | ||||
| Hod Hasharon, Israel | |||||
| Shalvata Mental Health Center |
| Brainsway |
| Principal Investigator: | Hilik Levkovits | Day care hospital director |
More Information
| Study ID Numbers: | SH-505 |
| First Received: | March 7, 2007 |
| Last Updated: | March 7, 2007 |
| ClinicalTrials.gov Identifier: | NCT00445237 |
| Health Authority: | Israel: Ministry of Health |
|
|
|